NANJING GAOKE COMPANY LIMITED Nanjing Gaoke Company Limited Share Price
Equities
600064
CNE000000PX6
Real Estate Development & Operations
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.43 CNY | +0.47% |
|
-1.68% | +6.46% |
| 26/04 | Nanjing Gaoke Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 26/01 | Nanjing Gaoke's Q4 Contracted Sales Drop 69% | MT |
| Sales 2022 | 4.49B 620M 51.67B | Sales 2023 | 4.73B 653M 54.46B | Capitalization | 10.45B 1.44B 120B |
|---|---|---|---|---|---|
| Net income 2022 | 2.4B 331M 27.64B | Net income 2023 | 1.56B 215M 17.95B | EV / Sales 2022 | 3.44 x |
| Net Debt 2022 | 3.99B 551M 45.9B | Net Debt 2023 | 4.54B 626M 52.21B | EV / Sales 2023 | 3.17 x |
| P/E ratio 2022 |
4.76
x | P/E ratio 2023 |
6.7
x | Employees | 562 |
| Yield 2022 |
6.35% | Yield 2023 |
-
| Free-Float | 54.96% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.47% | ||
| 1 week | -1.68% | ||
| Current month | +2.88% | ||
| 1 month | +3.54% | ||
| 3 months | +2.55% | ||
| 6 months | +5.41% | ||
| Current year | +6.46% |
1 week
6.28
6.50
1 month
6.236.65
Current year
5.716.65
1 year
5.717.40
3 years
5.658.21
5 years
5.658.98
10 years
2.9613.04
| Managers | Title | Age | Since |
|---|---|---|---|
Ke Jin Zhou
DFI | Director of Finance/CFO | 49 | 22/16/22 |
Bao Min Xiao
CHM | Chairman | 62 | 22/16/22 |
Yang Jun Lu
PSD | President | 53 | 01/09/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Min Xu
CHM | Chairman | 61 | 01/03/01 |
Yang Jun Lu
PSD | President | 53 | 01/09/01 |
Qiao Gen Feng
BRD | Director/Board Member | 63 | 22/16/22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 6.43 | +0.47% | 16,809,250 |
| 25/24/25 | 6.4 | -0.47% | 8,400,396 |
| 24/24/24 | 6.43 | +0.78% | 8,366,488 |
| 23/24/23 | 6.38 | -1.24% | 11,619,480 |
| 22/24/22 | 6.46 | -1.22% | 13,321,500 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
NANJING GAOKE COMPANY LIMITED is a China-based company, principally engaged in real estate and municipal businesses, medical health business and equity investment business. Its real estate business includes residential development, commercial operations and property management, among others. Its medical health business includes the research and development, manufacture and sales of pharmaceuticals. The Company operates its businesses primarily in Nanjing, Jiangsu province, China.
Calendar
30/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +6.46% | 1.54B | |
| -9.36% | 22.5B | |
| +9.02% | 10.79B | |
| -34.32% | 10.32B | |
| -28.99% | 7.2B | |
| -5.56% | 7.01B | |
| -0.34% | 6.53B | |
| -3.03% | 6.09B | |
| +12.96% | 3.57B | |
| -5.92% | 3.54B |
- Stock Market
- Equities
- 600064 Stock
